Stevanato Group STVN 深 滬
已收盤 08-07 16:00:00 美东时间
20.27
-0.020
-0.10%
華盛通- 最 高20.42
- 今 開20.05
- 成交量 30.64万股
- 最 低 19.95
- 昨 收 20.29
- 總市值 55.34亿
- 52周最高 27.9378
- 市盈率 靜 35.06
- 換手率 0.11%
- 52周最低 12.8278
- 委 比 50.00%
- 總股本 2.73亿
- 歷史最高 36.1189
- 量 比 0.54
- 振 幅 2.32%
- 歷史最低 12.8278
- 每 手 1
- 風險率 3.79%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Stevanato Group Lowers FY2026 GAAP EPS Guidance from $0.64-$0.69 to $0.62-$0.64; Lowers FY2026 Sales Guidance from $1.467B-$1.500B to $1.465B-$1.488B
Stevanato Group (NYSE:STVN) lowers FY2026 GAAP EPS guidance from $0.64-$0.69 to $0.62-$0.64. Lowers FY2026 sales outlook from $1.467 billion-$1.500 billion to $1.465 billion-$1.488 billion.
08-04 18:43
Stevanato Group reports Q2 results
Stevanato Group press release (STVN): Q2 Non-GAAP EPS of €0.14 Revenue of €302M (+7.9% Y/Y). Gross profit margin: 28.7%, up 60 basis points Y/Y. Adjusted EBITDA margin: 26.0%, up 280 basis points Y/Y....
08-04 18:43
Stevanato Group Narrows FY2026 Adj EPS Guidance from $0.69-$0.73 to $0.70-$0.72 vs $0.68 Est; Lowers FY2026 Sales Guidance from $1.467B-$1.500B to $1.465B-$1.488B vs $1.500B Est
Stevanato Group (NYSE:STVN) narrows FY2026 Adj EPS guidance from $0.69-$0.73 to $0.70-$0.72 vs $0.68 analyst estimate. Lowers FY2026 sales outlook from $1.467 billion-$1.500 billion to $1.465 billion-$1.488 billion vs $1.500 billion estimate.
08-04 18:40
Stevanato Group Says Liraglutide-Based Combination Products Incorporating Its Proprietary Alina Pen Injector Platform Receives Marketing Authorizations In Europe
The regulatory approvals cover therapies for diabetes and weight management, further expanding the commercial adoption of Stevanato Group's proprietary Alina® pen injector platform across Europe. Stevanato Group S.p.A. (NYSE:STVN), a leading global provider of drug containment, drug delivery and dia...
07-30 18:38
正川股份与斯蒂瓦纳托SPAMI达成深度战略合作
据正川股份（603976.SH）消息，近日，正川股份与意大利斯蒂瓦纳托集团（Stevanato Group（STVN.US））旗下SPAMI&nb...
07-23 14:07
重磅签约，战略升级｜正川股份 × 斯蒂瓦纳托 SPAMI 达成深度战略合作，重塑...
全球生物医药产业持续扩容，高端精密药玻包装、智能生产装备成为制剂产业高质量发展核心支撑，为加速国内医药包装产业高端化、智能化、国际化进程。近日，正川股份（60...
07-23 12:00
美股大行评级 | 潜在涨幅117.92%！摩根大通上调Camp4 Therapeutics目标价至9美元，维持"超配"评级
今日重点评级关注：摩根大通：上调Camp4 Therapeutics评级至"超配"，目标价从5美元升至9美元；Canaccord Genuity：维持Rhythm制药"买入"评级，目标价从143美元升至151美元
06-17 11:32
TD Cowen Initiates Coverage On Stevanato Group with Buy Rating, Announces Price Target of $25
TD Cowen initiates coverage on Stevanato Group (NYSE:STVN) with a Buy rating and announces Price Target of $25.
06-17 01:02
Merlin, Concrete Pumping Holdings, And Krispy Kreme And Other Big Stocks Moving Higher On Friday
U.S. stocks trade lower on Friday, Nasdaq down 425 points. Merlin shares rise 35.93% after successful CDR, other big stocks also record gains.
06-05 22:38
美股大行评级 | 潜在涨幅43%，慧与获11家大行集体上调目标价；最高300美元，Credo获9家大行集体上调目标价
今日重点评级关注：Ascendiant Capital：维持Genasys"买入"评级，目标价从5.5美元升至6美元；Citizens：维持Abivax"跑赢大市"评级，目标价从131美元升至187美元
06-03 11:17
